OBJECTIVES
Despite advances in biologic and targeted synthetic DMARDs (b/tsDMARDs), many patients with psoriatic arthritis (PsA) experience suboptimal responses and discontinue therapy. We aimed, in a real-world registry, to identify predictors of b/tsDMARD discontinuation and treatment response.
METHODS
Patients com...
O. Rotariu, Stephanie Lembke, P. Helliwell et al.· Rheumatology· 0 citations
Rheumatic and musculoskeletal diseases are chronic, heterogeneous conditions shaped by complex interactions between immune, metabolic, behavioural, and environmental factors. Despite substantial advances in pharmacological therapies, many patients continue to have pain, fatigue, functional impairment, and accumulating...
E. Lubrano, F. Perrotta, M. Fatica et al.· The Lancet Rheumatology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.